Taiwan cobra phospholipase A2 elicits posttranscriptional up-regulation of ADAM17 in human neuroblastoma SK-N-SH cells

Journal of Cellular Biochemistry

Volumn 111, Issue 1, 2010, Pages 148-157

  Liu, Wen Hsin ^a   Chen, Ku Chung ^a   Chiou, Yi Ling ^a   Lin, Shinne Ren ^b   Chang, Long Sen ^a  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

ADAM17; ERK; p38 MAPK; PLA2; Posttranscriptional up regulation

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; CATALYSIS; CELL SURFACE; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SNAKE; UPREGULATION;

ADAM PROTEINS; ANIMALS; CELL LINE, TUMOR; COBRA; COBRA VENOMS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; NEUROBLASTOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASES A2; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

NAJA ATRA;

EID: 77957148510     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22681     Document Type: Article

References (31)

1. Arribas J, Ruiz-Paz S. 2005. ADAM 17, regulation of ectodomain shedding. In: Hooper NM, Lendeckel U, editors. The ADAM family of proteases. Springer: The Netherlands. pp 171-197.
2. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 33:2643-2652.
3. Brill A, Chauhan A, Canault M, Walsh MT, Bergmeier W, Wagner DD. 2009. Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion. Cardiovas Res 84:137-144.
4. Buckley CA, Rouhani FN, Kaler M, Adamik B, Hawari FI, Levine SJ. 2005. Amino-terminal TACE prodomain attenuates TNFR2 cleavage independently of the cysteine switch. Am J Physiol 288:L1132-L1138. (Pubitemid 40695439)
5. Canault M, Tellier E, Bonardo B, Mas E, Aumailley M, Juhan-Vague I, Nalbone G, Peiretti F. 2006. FHL2 interacts with both ADAM-17 and the cytoskeleton and regulates ADAM-17 localization and activity. J Cell Physiol 208:363-372.
6. 2. J Biochem (Tokyo) 124:764-768.
7. 2+-mediated p38 MAPK activation. J Cell Biochem 106:93-102.
8. 2. Toxicon 51:270-279.
9. Chung AS, Guan YJ, Yuan ZL, Albina JE, Chin YE. 2005. Ankyrin repeat and SOCS Box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II. Mol Cell Biol 25:4716-4726.
10. Cisse MA, Sunyach C, Slack BE, Fisher A, Vincent B, Checler F. 2007. M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J Neurosci 27:4083-4092.
11. Coelho FM, Reis HJ, Nicolato R, Romano-Silva MA, Teixeira MM, Bauer ME, Teixeira AL. 2008. Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation 15:140-144.
12. Edwards DR, Handsley MM, Pennington CJ. 2008. The ADAM metalloproteinases. Mol Aspects Med 29:258-289.
13. Endres K, Anders A, Kojro E, Gilbert S, Fahrenholz F, Postina R. 2003. Tumor necrosis factor α converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. Eur J Biochem 270:2386-2393. (Pubitemid 36645356)
14. 2 activity in schizophrenia: A replication study. Biol Psychiatry 28:495-501.
15. Gonzales PE, Solomon A, Miller AB, Leesnitzer MA, Sagi T, Milla ME. 2004. Inhibition of the tumor necrosis factor α-converting enzyme by its prodomain. J Biol Chem 279:31638-31645.
16. 2+-mediated p38 MAPK activation and mitochondrial depolarization. Toxicol Lett 185:102-109.
17. Mezyk-Kopec R, Bzowska M, Stalinska K, Chelmicki T, Podkalicki M, Jucha J, Kowalczyk K, Mak P, Bereta J. 2009. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts. Cytokine 46:309-315.
18. Milla ME, Leesnitzer MA, Moss ML, Clay WC, Carter HL, Miller AB, Su JL, Lambert ME, Willard DH, Sheeley DM, Kost TA, Burkhart W, Moyer M, Blackburn RK, Pahel GL, Mitchell JL, Hoffman CR, Becherer JD. 1999. Specific sequence elements are required for the expression of functional tumor necrosis factor α-converting enzyme (TACE). J Biol Chem 274:30563-30570.
19. Mochizuki S, Okada Y. 2007. ADAMs in cancer cell proliferation and progression. Cancer Sci 98:621-628. (Pubitemid 46563436)
20. Peiretti F, Canault M, Deprez-Beauclair P, Berthet V, Bonardo B, Juhan- Vague I, Nalbone G. 2003a. Intracellular maturation and transport of tumor necrosis factor a converting enzyme. Exp Cell Res 285:278-285. (Pubitemid 36428959)
21. Peiretti F, Deprez-Beauclair P, Bonardo B, Aubert H, Juhan-Vague I, Nalbone G. 2003b. Identification of SAP97 as an intracellular binding partner of TACE. J Cell Sci 116:1949-1957. (Pubitemid 36622293)
22. Santiago-Josefat B, Esselens C, Bech-Serra JJ, Arribas J. 2007. Post-transcriptional up-regulation of ADAM-17 upon epidermal growth factor receptor activation and in breast tumors. J Biol Chem 282:8325-8331. (Pubitemid 47093613)
23. Schlondorff J, Becherer JD, Blobel CP. 2000. Intracellular maturation and localization of the tumour necrosis factor a convertase (TACE). Biochem J 347(Pt 1): 131-138. (Pubitemid 30199050)
24. Schulte M, Reiss K, Lettau M, Maretzky T, Ludwig A, Hartmann D, de Strooper B, Janssen O, Saftig P. 2007. ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death. Cell Death Differ 14:1040-1049.
25. Seals DF, Courtneidge SA. 2003. The ADAMs family of metalloproteinases: Multidomain proteins with multiple functions. Genes Dev 17:7-30.
26. Singh RJR, Mason JC, Lidington EA, Edwards DR, Nuttall RK, Khokha R, Knauper V, Murphy G, Gavrilovic J. 2005. Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovas Res 67:39-49.
27. Soond SM, Everson B, Riches DWH, Murphy G. 2005. ERK-mediated phosphorylation of Thr735 in TNFα-converting enzyme and its potential role in TACE protein trafficking. J Cell Sci 118:2371-2380. (Pubitemid 40873077)
28. Tellier E, Canault M, Poggi M, Bonardo B, Nicolay A, Alessi MC, Nalbone G, Peiretti F. 2008. HDLs activate ADAM17-dependent shedding. J Cell Physiol 214:687-693.
29. Wang Y, Herrera AH, Li Y, Belani KK, Walcheck B. 2009. Regulation of mature ADAM17 by redox agents for L-selectin shedding. J Immunol 182:2449-2457.
30. Xu P, Derynck R. 2010. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation. Mol Cell 37:551-566.
31. Zheng Y, Schlondorff J, Blobel CP. 2002. Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J Biol Chem 277:42463-42470. (Pubitemid 35285612)